These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Expanded access for delavirdine.
    Journal: Posit Aware; 1996; 7(3):5-6. PubMed ID: 11363426.
    Abstract:
    Delavirdine (Rescriptor) is available through an expanded access program. Pharmacia & Upjohn's non-nucleoside reverse transcriptase inhibitor works in combination with AZT to reduce viral loads and increase CD4 counts. Effects are sustained for as long as a year. Its most common side effect is rash.
    [Abstract] [Full Text] [Related] [New Search]